Tumor Necrosis Factor Soluble Receptor I (TNF sRI)/Fc Chimera human
SIGMA/T3439 - >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, suitable for cell culture
MDL Number: MFCD02689207
Product Type: Chemical
assay | >95% (SDS-PAGE) |
biological source | human |
form | lyophilized powder |
impurities | endotoxin, tested |
mol wt | 48 kDa |
packaging | pkg of 50 μg |
potency | 0.4-1 ng/mL ED50 |
Quality Level | 100 ![]() |
recombinant | expressed in NSO cells |
storage condition | avoid repeated freeze/thaw cycles |
storage temp. | −20°C |
technique(s) | cell culture | mammalian: suitable |
UniProt accession no. | P20333 ![]() ![]() |
Analysis Note: | The biological activity is measured by its ability to neutralize apoptosis of mouse L-929 cells treated with 0.25 ng/ml recombinant human TNF-α. |
Application: | Tumor Necrosis Factor Soluble Receptor I (TNF sRI)/Fc Chimera human may be used to study signaling of apoptosis and NF-κB activation. |
Biochem/physiol Actions: | Tumor Necrosis Factor Soluble Receptor I (TNF sRI)/Fc Chimera human belongs to TNF family of receptors and has a pivotal role in neutralizing the biological activities of both TNF-α and TNF-β. Soluble tumor necrosis factor receptor along with intrathecal interleukin-1 receptor antagonist shows an anti-allodynic action in rat L5 spinal nerve transection model of neuropathic pain. |
Physical form: | Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline with 2.5 mg bovine serum albumin. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | >95% (SDS-PAGE) |
Storage Temp. | −20°C |
UNSPSC | 51111800 |